O'Toole David D — SEC insider filings

SEC reporting owner CIK 1491140. 38 insider filings on record with FilingPulse; latest filed 2026-08-24.

Transaction summary — filings shown

Covers all 38 filings on record, filed 2021-01-27 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AVITA Medical, Inc. (RCEL)CFO2731 legs · 35,475 sh · $355,951—11
OPIANT PHARMACEUTICALS, INC. (OPNT)Chief Financial Officer113 legs · 800 sh · $13,0525 legs · 3,767 sh · $73,53012

Insider filings — O'Toole David D

FiledFormIssuerReported transactionsSource
2026-08-244/AAVITA Medical, Inc. (RCEL)Purchase (P): 2,000 @ $3.97EDGAR
2026-06-124AVITA Medical, Inc. (RCEL)Grant/award (A): 2,000 @ $3.97EDGAR
2026-06-014AVITA Medical, Inc. (RCEL)Grant/award (A): 5,000 @ $3.05EDGAR
2026-05-204AVITA Medical, Inc. (RCEL)Purchase (P): 2,000 @ $4.26EDGAR
2026-05-194AVITA Medical, Inc. (RCEL)Purchase (P): 2,000 @ $4.24EDGAR
2026-03-114AVITA Medical, Inc. (RCEL)Purchase (P): 1,800 @ $4.78EDGAR
2026-02-234AVITA Medical, Inc. (RCEL)Purchase (P): 3,000 @ $4.15EDGAR
2026-02-194AVITA Medical, Inc. (RCEL)Grant/award (A): 105,470 · Grant/award (A): 155,510 (derivative) @ $0EDGAR
2025-08-264AVITA Medical, Inc. (RCEL)Purchase (P): 2,000 @ $4.52EDGAR
2025-08-124AVITA Medical, Inc. (RCEL)Purchase (P): 2,000 @ $4.81EDGAR
2025-06-024AVITA Medical, Inc. (RCEL)Grant/award (A): 1,923 @ $4.78EDGAR
2025-02-204AVITA Medical, Inc. (RCEL)Purchase (P): 1,000 @ $9.90EDGAR
2025-02-194AVITA Medical, Inc. (RCEL)Purchase (P): 1,000 @ $10.25EDGAR
2025-01-224AVITA Medical, Inc. (RCEL)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2024-12-054AVITA Medical, Inc. (RCEL)Grant/award (A): 785 @ $7.83 · Purchase (P): 475 @ $12.53 · Purchase (P): 500 @ $12.40EDGAR
2024-06-034AVITA Medical, Inc. (RCEL)Purchase (P): 500 @ $9.20 · Purchase (P): 500 @ $8.60 · Grant/award (A): 2,240 @ $8.17EDGAR
2024-02-284AVITA Medical, Inc. (RCEL)Purchase (P): 1,000 @ $17.38 · Purchase (P): 250 @ $17.43EDGAR
2024-01-054AVITA Medical, Inc. (RCEL)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2023-12-124AVITA Medical, Inc. (RCEL)Purchase (P): 950 @ $12.45EDGAR
2023-12-044AVITA Medical, Inc. (RCEL)Grant/award (A): 1,034 @ $9.06 · Purchase (P): 500 @ $10.68EDGAR
2023-11-214AVITA Medical, Inc. (RCEL)Purchase (P): 1,000 @ $10.30 · Purchase (P): 1,000 @ $10.26EDGAR
2023-11-164AVITA Medical, Inc. (RCEL)Purchase (P): 1,000 @ $12.15 · Purchase (P): 1,000 @ $12.45EDGAR
2023-11-154AVITA Medical, Inc. (RCEL)Purchase (P): 1,000 @ $12.88 · Purchase (P): 1,000 @ $13.25EDGAR
2023-08-164AVITA Medical, Inc. (RCEL)Purchase (P): 1,000 @ $17.05 · Purchase (P): 1,000 @ $17.06EDGAR
2023-08-154AVITA Medical, Inc. (RCEL)Purchase (P): 1,000 @ $17.92 · Purchase (P): 1,000 @ $17.89 · Purchase (P): 1,000 @ $17.96 · Purchase (P): 1,000 @ $17.94 · Purchase (P): 1,000 @ $17.93EDGAR
2023-06-214AVITA Medical, Inc. (RCEL)Purchase (P): 1,000 @ $16.15EDGAR
2023-06-164AVITA Medical, Inc. (RCEL)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2023-03-034OPIANT PHARMACEUTICALS, INC. (OPNT)Disposition to issuer (D): 22,512 @ $20 · Disposition to issuer (D): 11,736 @ $20 · Grant/award (A): 2,000 @ $0 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 33,000 (derivative) @ $0 · Disposition to issuer (D): 8,250 (derivative) @ $0 · +1 moreEDGAR
2023-01-314OPIANT PHARMACEUTICALS, INC. (OPNT)Sale (S): 541 @ $20.26EDGAR
2023-01-094OPIANT PHARMACEUTICALS, INC. (OPNT)Sale (S): 415 @ $20.20EDGAR
2023-01-054OPIANT PHARMACEUTICALS, INC. (OPNT)Sale (S): 1,600 @ $20.20EDGAR
2022-07-154OPIANT PHARMACEUTICALS, INC. (OPNT)Sale (S): 779 @ $11.10EDGAR
2022-06-294OPIANT PHARMACEUTICALS, INC. (OPNT)Grant/award (A): 2,000 @ $0EDGAR
2022-01-124OPIANT PHARMACEUTICALS, INC. (OPNT)Sale (S): 432 @ $30.60EDGAR
2022-01-054OPIANT PHARMACEUTICALS, INC. (OPNT)Grant/award (A): 12,000 @ $0EDGAR
2021-09-154OPIANT PHARMACEUTICALS, INC. (OPNT)Purchase (P): 179 @ $19.13 · Purchase (P): 21 @ $19.05EDGAR
2021-08-164OPIANT PHARMACEUTICALS, INC. (OPNT)Purchase (P): 600 @ $15.38EDGAR
2021-01-274OPIANT PHARMACEUTICALS, INC. (OPNT)Grant/award (A): 2,450 @ $0 · Grant/award (A): 5,400 @ $0 · Grant/award (A): 10,750 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1491140 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs